Overview
Join us for an informative discussion on the evolving landscape of In Vitro Diagnostics (IVD) and Lab Developed Tests (LDTs). Our panel of industry leaders will delve into the latest developments from across the US, UK and Europe.
RU Okay? Understanding the Regulatory Landscape for Diagnostic Tests in the US, UK and EU
-
CapabilitiesCapabilities
-
ServicesServices
- Antitrust
- Business Restructuring
- Corporate & Transactional
- Crisis Management
- Employee Benefits & Executive Compensation
- Employment
- Global Privacy & Cybersecurity
- Global White-Collar & Government Investigations
- Government & Lobbying Strategies
- Government Contracts
- Intellectual Property
- International Trade
- Investment Management
- Litigation & Dispute Resolution
- Private Client & Wealth Management
- Real Estate
- Shareholder Activism
- Strategic Solutions
- Sustainability, Impact & ESG
- Tax
- Trade Secrets
-
-
-
InsightsInsightsALL INSIGHTS
Featured
View All
TaxHIRE Act would significantly impact outsourcing payments (but questions remain)
Private EquityEuropean healthcare investment in 2026: Outpatient services, optimisation, and optimism
Health & Life SciencesMedicare telehealth flexibilities expire: Immediate impacts and next steps-
ResourcesResources
- Al in Healthcare Law Center
- Alcohol M&A Resource Center
- Artificial Intelligence Law Center
- CORA
- Cross-Border Investment
- Dawn Raid Guide
- Direct Primary Care Arrangements
- Freelancer Compliance Check
- GESC
- Global Privacy & Cybersecurity Resource Center
- Health Transactions Law Center
- Information Blocking & Interoperability in Healthcare
- Investing in Healthcare Resource Center
- McDermott University | On-Demand CLE
- Navigating the New Energy Landscape Resource Center
- No Surprises Act Resource Center
- SECURE 2.0 Act
- Unified Patent Court Resource Center
- US Policy Watch
-
-